Clinicopathologic Characteristics and Treatment Outcomes of Penile Cancer
- PMID: 28459145
- PMCID: PMC5419113
- DOI: 10.5534/wjmh.2017.35.1.28
Clinicopathologic Characteristics and Treatment Outcomes of Penile Cancer
Abstract
Purpose: The aim of this study was to assess the clinicopathologic characteristics of penile cancer, including patterns of therapy, oncologic results, and survival.
Materials and methods: Between January 2005 and July 2015, 71 patients at 6 institutions who had undergone penectomy or penile biopsy were enrolled. Their medical records were reviewed to identify the mode of therapy, pathology reports, and cancer-specific survival (CSS) rate.
Results: Clinicopathologic and outcome information was available for 52 male patients (mean age, 64.3 years; mean follow-up, 61.4 months). At presentation, 17 patients were node-positive, and 4 had metastatic disease. Management was partial penectomy in 34 patients, total penectomy in 12 patients, and chemotherapy or radiotherapy in 6 patients. The pathology reports were squamous cell carcinoma in 50 patients and other types of carcinoma in the remaining 2 patients. Kaplan-Meier survival analysis showed a 5-year CSS rate of 84.0%. In univariate and multivariate analyses, the American Joint Committee on Cancer (AJCC) stage and pathologic grade were associated with survival.
Conclusions: Partial penectomy was the most common treatment of penile lesions. The oncologic outcomes were good, with a 5-year CSS of 84.0%. The AJCC stage and pathologic grade were independent prognostic factors for survival.
Keywords: Penile neoplasms; Prognosis; Treatment outcome.
Copyright © 2017 Korean Society for Sexual Medicine and Andrology
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Oncologic Outcomes of Penile Cancer Treatment at a UK Supraregional Center.Urology. 2015 May;85(5):1097-1103. doi: 10.1016/j.urology.2014.11.048. Epub 2015 Mar 10. Urology. 2015. PMID: 25769781
-
Prognostic Factors of Penile Cancer and the Efficacy of Adjuvant Treatment after Penectomy: Results from a Multi-institution Study.J Korean Med Sci. 2018 Jul 25;33(37):e233. doi: 10.3346/jkms.2018.33.e233. eCollection 2018 Sep 10. J Korean Med Sci. 2018. PMID: 30190657 Free PMC article.
-
Preoperative peripheral plasma fibrinogen level is an independent prognostic marker in penile cancer.Oncotarget. 2017 Feb 14;8(7):12355-12363. doi: 10.18632/oncotarget.12563. Oncotarget. 2017. PMID: 27738342 Free PMC article.
-
[Diagnosis and therapy for penile cancer: a report of 46 cases with literature review].Ai Zheng. 2008 Sep;27(9):962-5. Ai Zheng. 2008. PMID: 18799036 Review. Chinese.
-
Local Therapy and Reconstruction in Penile Cancer: A Review.Cancers (Basel). 2024 Jul 30;16(15):2704. doi: 10.3390/cancers16152704. Cancers (Basel). 2024. PMID: 39123432 Free PMC article. Review.
Cited by
-
Venous thrombosis, multiple carcinomatous foci and differences in metastatic pathways of penile carcinoma.Oncol Lett. 2023 Jan 17;25(3):88. doi: 10.3892/ol.2023.13674. eCollection 2023 Mar. Oncol Lett. 2023. PMID: 36817041 Free PMC article.
-
Challenging the prognostic impact of the new WHO and TNM classifications with special emphasis on HPV status in penile carcinoma.Virchows Arch. 2019 Aug;475(2):211-221. doi: 10.1007/s00428-019-02566-0. Epub 2019 Apr 10. Virchows Arch. 2019. PMID: 30972551
-
HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights.Pathogens. 2024 Sep 18;13(9):809. doi: 10.3390/pathogens13090809. Pathogens. 2024. PMID: 39339000 Free PMC article. Review.
References
-
- Korean Ministry of Health and Welfare & Korean National Cancer Information Center 2015. Cancer in Korea [Internet] Goyang: National Cancer Center; c2016. [cited 2016 Jun 5]. Available from: http://www.cancer.go.kr.
-
- Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27:141–150. - PubMed
-
- Skeppner E, Andersson SO, Johansson JE, Windahl T. Initial symptoms and delay in patients with penile carcinoma. Scand J Urol Nephrol. 2012;46:319–325. - PubMed
-
- American Joint Committee on Cancer (AJCC) Penis. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. pp. 447–455.
LinkOut - more resources
Full Text Sources
Other Literature Sources